Priser
Platform
Blog
Om os
Download
000078
Shenzhen Neptunus Bioengineering Co
Shenzhen Stock Exchange (Hong Kong)
0

Om

Shenzhen Neptunus Bioengineering Co., Ltd. operates as a leading player in the pharmaceutical and biotechnology sector in China. The company's primary function is the research, development, production, and distribution of biopharmaceutical products, which include vaccines, diagnostic reagents, and various bioactive substances. With a strong focus on innovative healthcare solutions, Shenzhen Neptunus Bioengineering is committed to improving public health through its diverse product portfolio. The company has a significant impact on the healthcare and wellness industries, playing a crucial role in advancing medical treatments and preventative healthcare measures. Headquartered in Shenzhen, a major economic hub, the company leverages its strategic location to cater to both domestic and international markets, reinforcing China's burgeoning presence in the global pharmaceutical industry. As it continues to expand its reach, Shenzhen Neptunus Bioengineering is an emblem of China's growing expertise and innovation within the biotechnological space.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I SHENZHEN NEPTUNUS BIOENGINEERING CO MED ENDAVU: Køb Shenzhen Neptunus Bioengineering Co ($000078) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Shenzhen Neptunus Bioengineering Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker000078
Land
Kina
Antal medarbejdere8.264
Hjemmesideneptunusbio.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0CNH
'01
0,07CNH
'18
0,02CNH
'19
Ex-udbytte-dato16. jul. 2019
Udbytteafkast0%